Cargando…

Structural basis for the inhibition of human angiotensin‐1 converting enzyme by fosinoprilat

Human angiotensin I‐converting enzyme (ACE) has two isoforms, somatic ACE (sACE) and testis ACE (tACE). The functions of sACE are widespread, with its involvement in blood pressure regulation most extensively studied. sACE is composed of an N‐domain (nACE) and a C‐domain (cACE), both catalytically a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cozier, Gyles E., Newby, Emma C., Schwager, Sylva L. U., Isaac, R. Elwyn, Sturrock, Edward D., Acharya, K. Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796954/ https://www.ncbi.nlm.nih.gov/pubmed/35653492 http://dx.doi.org/10.1111/febs.16543

Ejemplares similares

Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme
por: Sharma, Urvashi, et al.
Publicado: (2020)

Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
por: Masuyer, Geoffrey, et al.
Publicado: (2012)

Angiotensin‐converting enzyme open for business: structural insights into the subdomain dynamics
por: Cozier, Gyles E., et al.
Publicado: (2020)

Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril
por: Akif, Mohd, et al.
Publicado: (2011)

Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin‐I converting enzyme
por: Masuyer, Geoffrey, et al.
Publicado: (2013)

Crystal structures of sampatrilat and sampatrilat‐Asp in complex with human ACE – a molecular basis for domain selectivity
por: Cozier, Gyles E., et al.
Publicado: (2018)

Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)
por: Yates, Christopher J., et al.
Publicado: (2014)

The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae
por: Abu Hasan, Zatul-’Iffah, et al.
Publicado: (2017)

Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide
por: Akif, Mohd, et al.
Publicado: (2011)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
por: Larmuth, Kate M., et al.
Publicado: (2016)

Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster
por: Akif, Mohd, et al.
Publicado: (2012)

Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
por: Masuyer, Geoffrey, et al.
Publicado: (2015)

The N Domain of Human Angiotensin-I-converting Enzyme: THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407
por: Anthony, Colin S., et al.
Publicado: (2010)

ACE-domain selectivity extends beyond direct interacting residues at the active site
por: Cozier, Gyles E., et al.
Publicado: (2020)

ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
por: Lubbe, Lizelle, et al.
Publicado: (2020)

Characterization of the first angiotensin-converting like enzyme in bacteria: Ancestor ACE is already active
por: Rivière, Guillaume, et al.
Publicado: (2007)

Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors
por: Douglas, Ross G., et al.
Publicado: (2013)

The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae
por: Burnham, Susan, et al.
Publicado: (2005)

A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP
por: Danilov, Sergei M., et al.
Publicado: (2014)

Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization
por: Lubbe, Lizelle, et al.
Publicado: (2022)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
por: Zaheer, Sarah, et al.
Publicado: (2017)

Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
por: Kiss, István, et al.
Publicado: (2014)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition
por: Arman, Q.
Publicado: (2010)

Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension
por: Alves-Lopes, Rhéure, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

A new high-resolution crystal structure of the Drosophila melanogaster angiotensin converting enzyme homologue, AnCE
por: Harrison, Charlotte, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors
por: Fang, Li, et al.
Publicado: (2019)

Mechanistic Insights into Angiotensin I-Converting Enzyme Inhibitory Tripeptides to Decipher the Chemical Basis of Their Activity
por: Lammi, Carmen, et al.
Publicado: (2022)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
por: Turner, Jeffrey M., et al.
Publicado: (2020)

The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease
por: Jochemsen, Hadassa M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_96cqtfi3ejrjsfgeg8eke3n4d3